Now approved in the US: PAPZIMEOS^™

Learn more about PAPZIMEOS (zopapogene imadenovec-drba) for subcutaneous injection 5×10¹¹ PU/mL

• Read press releases from Precigen, FDA, RRPF
• Read Precigen’s press release on RRPF-sponsored expert consensus paper
• Read long-term follow-up results
• Visit the product website
• Read the full prescribing information